[Gynecological aspects of thrombocytopenia].
D000328:Adult; D000700:Analgesics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D005260:Female; D005831:Genital Diseases, Female / Q000150:complications*; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006728:Hormones / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011644:Puerperal Disorders / Q000150:complications*; D011802:Quinidine / Q000009:adverse effects; D013449:Sulfonamides / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced / Q000209:etiology*
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D003276:Contraceptives, Oral; D004232:Diuretics; D006634:Histamine H1 Antagonists; D006728:Hormones; D006993:Hypnotics and Sedatives; D013449:Sulfonamides; D010672:Phenytoin; D011802:Quinidine
Aspetti ginecologici delle piastrinopenie.